Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
AACR Annual Meeting 2021
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
European Lung Cancer Virtual Congress 2021
SGO 2021 Virtual Annual Meeting on Womens Cancer
NCCN 2021 Virtual Annual Conference
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Roundtable:
Lymphoma/Myeloma
Roundtable:
Lung Cancer
Podcasts
CME
Methotrexate–Induced Kidney Injury
Advertisement
Advertisement
Op-Ed
Advertisement
Advertisement
Apr
15
Today In Oncology
Tebentafusp First Treatment to Improve Overall Survival in Metastatic Uveal Melanoma
Certain Genetic Mutations May Increase Risk of Death From Infection in Patients With CLL
New Study Finds Baseline Brain Imaging Should Be Considered for Patients With Metastatic RCC
FDA Approves Idecabtagene Vicleucel for Heavily Pretreated Patients With Multiple Myeloma
Addition of Alpelisib to Fulvestrant for PIK3CA-Mutant HR-Positive HER2-Negative Advanced Breast Cancer Patient-Reported Outcomes
View More
Advertisement
